Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of TVAX-008 in chronic hepatitis B
CTR20250030Phase 2Active
- Sponsor
- Sciwind Biosciences
- Start
- Jan 2025
- Modality
- Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of TVAX-008 in Chronic Hepatitis B (CHB), sponsored by Sciwind Biosciences. Started Jan 2025; status: active.
02
Drugs
TVAX-008
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20250030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250030.